A Systematic Review and Meta-Analysis on Long-Term Exposure to Particulate Matter and All-Cause and Cause-Specific Mortality in the Asia-Pacific States

亚太地区长期暴露于颗粒物与全因死亡率和特定原因死亡率的系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Global Burden of Disease (GBD) studies have proposed integrated exposure-response models primarily based on North American and European data, which may not be directly applicable to the Asia-Pacific region. Through a systematic review and meta-analysis, we aimed to explore the association between long-term exposure to ambient particulate matter (PM) and mortality in the Asia-Pacific states. METHODS: We searched 3 databases (PubMed [n = 8,326], Embase [n = 4,709], and Cochrane Library [n = 357]) between 1st January 1990 and 31st July 2023. Our search focused on studies examining the associations between long-term exposure to PM with an aerodynamic diameter < 2.5 μm (PM(2.5)) and 10 μm (PM₁₀) and all-cause (or non-accidental) and cause-specific mortality, including cardiovascular disease (CVD), ischemic heart disease (IHD), stroke, acute lower respiratory infection, chronic obstructive pulmonary disease, and lung cancer deaths in the Asia-Pacific states. We conducted a meta-analysis to pool the estimates in the studies. RESULTS: We identified 71 articles investigating the association between long-term exposure to PM and all-cause and cause-specific mortality. For a 10 μg/m³ increase in PM(2.5), the pooled relative risk (RR) with 95% confidence intervals (CI) for all-cause mortality was 1.11 (95% CI, 1.05-1.17), 1.13 (95% CI, 1.06-1.21) for CVD, 1.13 (95% CI, 1.02-1.25) for IHD, 1.12 (95% CI, 1.02-1.24) for stroke, and 1.12 (95% CI, 1.08-1.16) for lung cancer. For a 10 μg/m³ increase in PM₁₀, the pooled RR for all-cause mortality was 1.12 (95% CI, 1.00-1.24) and 1.33 (95% CI, 1.28-1.38) for IHD. CONCLUSION: Our analysis revealed positive associations between long-term exposure to PM and all-cause and cause-specific mortality for CVD, IHD, stroke, and lung cancer in the Asia-Pacific states. TRIAL REGISTRATION: PROSPERO Identifier: CRD42023441916.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。